PAA is the only Oncology company to have carried out a Phase II Human Trial and have a MC under $100m.
Regulatory Permission was given back in 2016 to reformulate and carry out a Phase IIb Human Trial .... reformulation has been on the agenda for 5 years now.
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366350 PAA Human Cancer Trial Link.
. Sufficient data was obtained to permit proceeding to Phase II study, i.e. a safe and active dose. The study was also terminated to permit reformulation of study drug to a more palatable formulation
Quarterly will be out in 10 days... I hope PAA aren't saving news for that....
Maybe an idea to have the CEO in the same Hemisphere as the company??
- Forums
- ASX - By Stock
- PAA
- Covi-Pantel . NZ Trader Release
Covi-Pantel . NZ Trader Release, page-1422
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
21.0¢ |
Change
0.015(7.69%) |
Mkt cap ! $93.45M |
Open | High | Low | Value | Volume |
20.0¢ | 21.5¢ | 19.5¢ | $459.0K | 2.222M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 103700 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 127225 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 15000 | 0.210 |
2 | 103700 | 0.205 |
5 | 220526 | 0.200 |
9 | 967873 | 0.195 |
16 | 611584 | 0.190 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 15000 | 1 |
0.215 | 127225 | 3 |
0.220 | 149118 | 3 |
0.230 | 51179 | 1 |
0.240 | 25634 | 1 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |